Evidence map›Paper›PMID 28068512›Full record

ArticleThe American journal of pathology2017

Modulation of Intersectin-1s Lung Expression Induces Obliterative Remodeling and Severe Plexiform Arteriopathy in the Murine Pulmonary Vascular Bed.

Monal Patel, Dan Predescu, Cristina Bardita, Jiwang Chen, Niranjan Jeganathan, Melanie Pritchard, Salvatore DiBartolo, Roberto Machado, Sanda Predescu

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Signaling pathways and targeted therapy for pulmonary hypertension.Signal transduction and targeted therapy · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Monal PatelDepartment of Pharmacology & Internal Medicine, Division of Pulmonary and Critical Care, Rush University Medical Center, Chicago, Illinois; Department of Pharmacology, Rush University Medical Center, Chicago, Illinois.
Dan PredescuDepartment of Pharmacology & Internal Medicine, Division of Pulmonary and Critical Care, Rush University Medical Center, Chicago, Illinois; Department of Pharmacology, Rush University Medical Center, Chicago, Illinois.
Cristina BarditaDepartment of Pharmacology, Rush University Medical Center, Chicago, Illinois.
Jiwang ChenDivision of Pulmonary, Critical Care, Sleep and Allergy, University of Illinois at Chicago, Chicago, Illinois.
Niranjan JeganathanDepartment of Pharmacology, Rush University Medical Center, Chicago, Illinois.
Melanie PritchardDepartment of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Victoria, Australia.
Salvatore DiBartoloDepartment of Pharmacology, Rush University Medical Center, Chicago, Illinois.
Roberto MachadoDivision of Pulmonary, Critical Care, Sleep and Allergy, University of Illinois at Chicago, Chicago, Illinois.
Sanda PredescuDepartment of Pharmacology, Rush University Medical Center, Chicago, Illinois. Electronic address: sanda_predescu@rush.edu.
Rush University Medical Center · USUniversity of Illinois Chicago · USMonash University · AU

Funding

Role of Sphingolipid Pathways in the Pathobiology of PAHR01HL127342 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MACHADO, ROBERTO F., NATARAJAN, VISWANATHAN · 2016 to 2023
$4.5M
Cleavage of Intersectin-1s by Granzyme B and Pulmonary Arterial HypertensionR01HL127022 · NHLBI · RUSH UNIVERSITY MEDICAL CENTER · PI PREDESCU, SANDA A · 2015 to 2024
$3.1M
Intersectin-1s regulates lung vascular permeability and endothelial cell survivalR01HL089462 · NHLBI · RUSH UNIVERSITY MEDICAL CENTER · PI PREDESCU, SANDA A · 2008 to 2012
$2.1M
NHLBI NIH HHS R01 HL089462NHLBI NIH HHS R01 HL127022NHLBI NIH HHS R01 HL127342
6 · The paper itself

Abstract

Murine models of pulmonary arterial hypertension (PAH) that recapitulate the plexiform and obliterative arteriopathy seen in PAH patients and help in defining the molecular mechanisms involved are missing. Herein, we investigated whether intersectin-1s (ITSN) deficiency and prolonged lung expression of an ITSN fragment with endothelial cell (EC) proliferative potential (EH

Indexed as

Vascular RemodelingAdaptor Proteins, Vesicular TransportAnimalsCell ProliferationCollagenEndothelial Cellsets-Domain Protein Elk-1Heart VentriclesHypertension, PulmonaryHypertrophyLipidsLungMicep38 Mitogen-Activated Protein KinasesProto-Oncogene Proteins c-mycPulmonary ArteryAdaptor Proteins, Vesicular TransportCollagenets-Domain Protein Elk-1intersectin 1Lipidsp38 Mitogen-Activated Protein KinasesProto-Oncogene Proteins c-mycRNA, Small Interfering

Identifiers

PMID28068512
PMCPMC5389368
OpenAlexW2571331043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.